Yiqiao Chen

Yiqiao Chen, Fazheng Xu, Zijian Huang et al.

Cardiovascular disease (CVD) is a leading cause of morbidity and mortality worldwide, and sustained hypertension is an often silent risk factor, making cuffless continuous blood pressure (BP) monitoring with wearable devices important for early screening and long-term management. Most existing cuffless BP estimation methods use only photoplethysmography (PPG) and electrocardiography (ECG) signals, alone or in combination. These models are typically developed under resting or quasi-static conditions and struggle to maintain robust accuracy in multi-motion-state scenarios. In this study, we propose a six-modal BP estimation framework that jointly leverages ECG, multi-channel PPG, attachment pressure, sensor temperature, and triaxial acceleration and angular velocity. Each modality is processed by a lightweight branch encoder, contrastive learning enforces cross-modal semantic alignment, and a mixture-of-experts (MoE) regression head adaptively maps the fused features to BP across motion states. Comprehensive experiments on the public Pulse Transit Time PPG Dataset, which includes running, walking, and sitting data from 22 subjects, show that the proposed method achieves mean absolute errors (MAE) of 3.60 mmHg for systolic BP (SBP) and 3.01 mmHg for diastolic BP (DBP). From a clinical perspective, it attains Grade A for SBP, DBP, and mean arterial pressure (MAP) according to the British Hypertension Society (BHS) protocol and meets the numerical criteria of the Association for the Advancement of Medical Instrumentation (AAMI) standard for mean error (ME) and standard deviation of error (SDE).

Yiqiao Chen

Cardiovascular disease (CVD) is a major pediatric health burden, and early screening is of critical importance. Electrocardiography (ECG), as a noninvasive and accessible tool, is well suited for this purpose. This paper presents the first benchmark study of deep learning for multi-label pediatric CVD classification on the recently released ZZU-pECG dataset, comprising 3716 recordings with 19 CVD categories. We systematically evaluate four representative paradigms--ResNet-1D, BiLSTM, Transformer, and Mamba 2--under both 9-lead and 12-lead configurations. All models achieved strong results, with Hamming Loss as low as 0.0069 and F1-scores above 85% in most settings. ResNet-1D reached a macro-F1 of 94.67% on the 12-lead subset, while BiLSTM and Transformer also showed competitive performance. Per-class analysis indicated challenges for rare conditions such as hypertrophic cardiomyopathy in the 9-lead subset, reflecting the effect of limited positive samples. This benchmark establishes reusable baselines and highlights complementary strengths across paradigms. It further points to the need for larger-scale, multi-center validation, age-stratified analysis, and broader disease coverage to support real-world pediatric ECG applications.